Q-linea AB (FRA:3F80) Long-Term Debt: kr9.43 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3F80 Q-linea AB FRA:3F80
65 GF Score
Price kr1.49
GF Value kr1.72
! 3 Warning Signs
View Full Analysis

What is Q-linea AB Long-Term Debt?

Q-linea AB FRA:3F80 65 Long-Term Debt is kr9.43 Mil as of Jun. 2026. GuruFocus rates FRA:3F80 with a GF Score™ of 65/100 and a GF Value™ of kr1.72. The stock has 3 warning signs investors should review.

Q-linea AB's Long-Term Debt for the quarter that ended in Jun. 2026 was kr9.43 Mil.

Q-linea AB's quarterly Long-Term Debt stayed the same from Dec. 2025 (kr0.00 Mil) to Mar. 2026 (kr0.00 Mil) but then increased from Mar. 2026 (kr0.00 Mil) to Jun. 2026 (kr9.43 Mil).

Q-linea AB's annual Long-Term Debt increased from Dec. 2023 (kr0.00 Mil) to Dec. 2024 (kr40.50 Mil) but then declined from Dec. 2024 (kr40.50 Mil) to Dec. 2025 (kr0.00 Mil).

Q-linea AB  (FRA:3F80) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Q-linea AB Long-Term Debt Related Terms

Q-linea AB Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Q-linea AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-linea AB Long-Term Debt Chart

Q-linea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 40.50 0.00

Q-linea AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.50 0.00 0.00 0.00 9.43
FRA:3F80
65GF Score
Q-linea AB FRA:3F80
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of kr9.43 Mil mean?
Q-linea AB (FRA:3F80) has a Long-Term Debt of kr9.43 Mil as of Jun. 2026.
Is Q-linea AB's Long-Term Debt too high?
Q-linea AB's current Long-Term Debt is kr9.43 Mil. Overall, Q-linea AB has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Long-Term Debt compare to ABT and SYK?
Q-linea AB's Long-Term Debt of kr9.43 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Q-linea AB's current Long-Term Debt is kr9.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Q-linea AB (FRA:3F80) has a current Long-Term Debt of kr9.43 Mil. The stock's GF Value™ is kr1.72, compared to a current price of kr1.49 — trading 13.4% below its estimated fair value. The current Long-Term Debt is kr9.43 Mil. Q-linea AB's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Q-linea AB (FRA:3F80), the current Long-Term Debt is kr9.43 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Q-linea AB (FRA:3F80) Overvalued in 2026?

Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued. The current stock price of kr1.49 is trading 13.4% below its estimated GF Value™ of kr1.72.

Key valuation signals for FRA:3F80:

  • Long-Term Debt: kr9.43 Mil
  • GF Value™: kr1.72 vs. price of kr1.49 (13.4% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the FRA:3F80 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Q-linea AB Business Description

Other Exchanges QLINEA:Sweden
Address Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
65GF Score

Get the complete analysis for FRA:3F80

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.49
Price
kr1.72
GF Value